RankingsPricing
  1. JP-listed companies
  2. KOBAYASHI PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Earnings per share

KOBAYASHI PHARMACEUTICAL CO.,LTD.【JP:4967】

Market cap
¥428.3B
P/E ratio
38.9x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndEarnings per share (JPY)YoY (%)
Dec 31, 2024135.4-49.50%
Dec 31, 2023268.2+3.29%
Dec 31, 2022259.6+2.88%
Dec 31, 2021252.4+2.71%
Dec 31, 2020245.7+0.67%
Dec 31, 2019244.1+7.03%
Dec 31, 2018228.1+13.28%
Dec 31, 2017201.3+12.39%
Dec 31, 2016179.1-45.90%
Mar 31, 2016331.1+8.40%
Mar 31, 2015305.5+1.63%
Mar 31, 2014300.6+1.07%
Mar 31, 2013297.4+3.84%
Mar 31, 2012286.4

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)